Skip to content
StockMarketAgent
Consumer Staples / Packaged FoodsUpdated 2026-05-10 22:07 UTC

VIE/BIO stock hub

VIE/BIO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

VIE/BIOis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
11.8M
Vienna Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
VIE/BIO
In the news

Latest news · VIE/BIO

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC-31.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All VIE/BIO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
108
Groups with data
9
Currency
EUR
Showing 108 of 108 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

15
MetricValue
Country
Austria
Country code
AT
Exchange
Vienna Stock Exchange
Financial currency
EUR
First seen
2026-05-10
Industry
Packaged Foods
Isin
ATBIOGENA005
Last refreshed
2026-05-10
Market cap
EUR 11.8M
Price
EUR 2.96
Price currency
EUR
Sector
Consumer Staples
Sic
6799
Symbol
vie/BIO
Website
https://biogenagroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

1
MetricValue
PE Ratio5 Y
-18.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

4
MetricValue
Gross Profit Growth
-77.67%
Roa5y
-20.77
ROIC
-31.38
Roic5y
-34.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr1y
60.92%
Cagr3y
5.06%
Cagr5y
0.88%
Div CAGR3
-20.63%
Revenue Growth
-45.81x
Revenue Growth Q
-77.78x
Revenue Growth3 Y
-10.88x
Revenue Growth5 Y
5.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

3
MetricValue
Current Assets
EUR 4.8M
Current Liabilities
EUR 2.6M
WACC
8.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

8
MetricValue
Dividend Growth
66.67%
Dividend Growth Years
1%
Dividend per share
EUR 0.05
Dividend Years
5
Dividend Yield
1.69%
Ex Div Date
2025-04-15
Last Dividend
EUR 0.05
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
60.87%
200-day SMA
3.01
3Y total return
15.97%
50-day SMA
3.03
50-day SMA vs 200-day SMA
50over200
5Y total return
4.47%
All Time High
7.55
All Time High Change
-60.79%
All Time High Date
2020-11-30
All Time Low
1.4
All Time Low Change
111.43%
All Time Low Date
2024-10-04
ATR
0.12
Beta
0.72
Beta1y
-0.28
Beta2y
0.08
Ch YTD
-1.33
High
3.06
High52
3.2
High52 Date
2025-10-30
High52ch
-7.5%
Low
2.96
Low52
1.65
Low52 Date
2025-05-20
Low52ch
79.39%
Ma50ch
-2.34%
Price vs 200-day SMA
-1.53%
RSI
47.54
RSI Monthly
60.53
RSI Weekly
49.38
Sharpe ratio
1.36x
Sortino ratio
2.31
Total Return
1.69%
Tr YTD
-1.33
Tr1m
-4.52%
Tr1w
4.23%
Tr3m
-3.27%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

2
MetricValue
Net Borrowing
-929,700
Shares Out
3,989,998

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

30
MetricValue
Average Volume
3,100.25x
Ch1m
-4.52
Ch1w
4.23
Ch1y
60.87
Ch3m
-3.27
Ch3y
11.28
Ch5y
-5.13
Ch6m
-2.63
Change
-1.99%
Change From Open
-3.27
Close
3.02
Days Gap
1.32
Depreciation Amortization
401,300
Dollar Volume
3,472.1
F Score
0
Fiscal Year End
December
Is Primary Listing
1
Last Report Date
2024-03-31
Ma150
3.01
Ma150ch
-1.69%
Ma20
2.98
Ma20ch
-0.7%
Open
3.06
Payment Date
2025-04-17
Position In Range
0
Ppne
5,848,200
Price Date
2026-05-08
Relative Volume
0.38x
Tr6m
-2.63%
Volume
1,173
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

VIE/BIO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.7%
$0.05 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
1 consecutive years of growth
Total shareholder yield
+1.7%
Next ex-dividend date: 2025-04-15
Performance

VIE/BIO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+60.9%
S&P 500 1Y: n/a
3Y total return
+16.0%
S&P 500 3Y: n/a
5Y total return
+4.5%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Technical

VIE/BIO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
47.5
Neutral momentum band
Price vs 200-day MA
-1.5%
50/200-day relationship not available
Beta (5Y)
0.72
Less volatile than the market
Sharpe ratio
1.36
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About VIE/BIO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current vie/BIO stock rating?

vie/BIO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full vie/BIO analysis?

The full report lives at /stocks/vie/BIO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for vie/BIO?

The latest report frames vie/BIO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the vie/BIO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

vie/BIO stock profile: metrics, valuation and analysis | เอเจนต์ AI ตลาดหุ้น